C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

Size: px
Start display at page:

Download "C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to"

Transcription

1 C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon

2 Company profile Company profile ChemCon offers outstanding chemical services for customers all over the world. The company is a leading manufacturer of fine chemicals and small to medium scale APIs used in all clinical stages as well as for commercial use. Today, more than 60 employees supply products and services to North America, Europe, the Middle East, India, Japan and Australia. 1992: ChemCon s roots date back to when one founder was involved in the development of synthesis strategies of active pharmaceutical ingredients at the University of Freiburg. Know-how acquired in this area forms the basis of the company s success : The two founders complete their PhDs in the field of bio-inorganic chemistry combined with peptide synthesis and rare analytical methods which provides a broad and in-depth scientific background. 1997: ChemCon is founded and starts offering customer-oriented chemical services in Freiburg, Germany. 1998: The first clean room enters service; the first multi-kilogram API synthesis campaign starts under full GMP compliance. 1999: The first development laboratory enters service and R&D services can now be offered. 2000: ChemCon s first FDA inspection and facility approval (no deficiency). ChemCon becomes Germany s youngest company to receive this proof of highest quality. The project, for which this inspection took place, receives the fastest NDA approval for an anti-cancer treatment in FDA history, achieved together with ChemCon s customer. This demonstrates the high speed of our services. 2001: The first analytical equipment (MP and FT-IR) enters service; ChemCon starts offering broad analytical services. 2003: ChemCon starts in-house education, and develops its own well-educated scientists and chemical professionals following certification for apprenticing. 2004: ChemCon receives the Baden-Wuerttemberg L-Bank Award, demonstrating excellent management skills. Our continuous economic development allows us to be a stable and reliable partner for our customers. 2009: ChemCon wins the STEP Award for its dedicated-equipment-strategy the best option to avoid cross contamination issues within small to medium scale API production. Also, ChemCon receives ISO 9001 certification demonstrating the quality of the whole operation. 2013: ChemCon receives approval from the German health authorities to start drug product manufacturing for clinical phases, including development services. ChemCon offers the whole range of drug development. Highest Quality In Small Volumes

3 Customer services Customer services ChemCon offers a combination of contract research and custom synthesis with integrated custom manufacturing. Our emphasis is on chemical development and the manufacturing of small organic and inorganic molecules in the field of active pharmaceutical ingredients (APIs) and innovative chemicals for research purposes. With our expertise in process optimization and scale-up, while maintaining outstanding product quality, ChemCon s main strength is the transfer from R&D into cgmp in our FDA inspected clean room facilities. Our experience with multi-step chemical synthesis, our versatile manufacturing capabilities and our skilled employees make ChemCon your good manufacturing partner for a broad spectrum of custom synthesis services - delivered on time, to the required specification and cost-effectively. We provide all necessary analytical and regulatory services for supporting critical project milestones. These services cover all phases of drug development to regulatory approval and commercial production with cgmp compliance. We are focused on small scale production of high quality products and have excellent experience in the synthesis of small organic molecules, APIs as well as HPAPIs.

4 Early Stage R&D Services Early Stage R&D Services ChemCon adopts projects at all stages of development, including projects from scratch, early preclinical development and commercial manufacturing. Our flexible service portfolio provides innovative organic and inorganic chemical solutions to support timely and efficient chemical development with improved cost efficiency. ChemCon s expertise and services include: literature research route scouting and optimization establishment of analytical methods scale-up from mg to kg You get: full intellectual property synthesis know-how analytical method development technical grade APIs for: - in vitro testing - toxicity studies - formulation development - impurity profile determination

5 Transfer to GMP Transfer to GMP The transfer of a chemical process from the development stage to GMP manufacturing is a challenging and demanding task and the key competence of ChemCon. Therefore, an expert understanding and constant improvement of production processes and regulatory support is a key factor for being successful in a competitive market. ChemCon supports the transfer to GMP for all clinical phases and provides the services you need: manufacturing of small volumes in different clean rooms creation of all necessary documents CMC section support analytical validation stability studies You get: precise GMP documentation analytical release packages products for in vivo testing for all clinical phases stability data

6 Commercial chemical and API production Commercial chemical and API production Utilizing our long term know-how and advanced technologies we have all the capabilities required to manufacture fine chemicals and high quality APIs. All our API batches bear a certificate of compliance and are manufactured following cgmp regulations according to ICH Q7 guidelines. Furthermore we offer high containment operations for the manufacturing of cytotoxic and other highly potent APIs. ChemCon manufactures valuable chemicals of high purity on demand, capitalizing on our experience in complex multi-step synthesis of APIs. Our core strengths in this field are: process validation routine production up to hundreds of kg in-house regulatory support handling of controlled substances / HPAPI supply clean rooms to manufacture injectable, ophthalmic, oral or topic grade APIs You get: routine API supply in small to medium scale orphan disease APIs highly potent APIs controlled substances

7 Drug product manufacturing Drug product manufacturing In 2013 ChemCon received the approval for drug product manufacturing for human use in semisolid topic grade. We plan to expand into this sector and develop other dosage forms in cooperation with our customers. With this approach our manufacturing capabilities are being expanded step by step and designed to meet current and future customer needs. With the development and manufacturing of pharmaceutical formulations we are able to offer the full range in drug development. ChemCon offers the following services for finished dosage forms intended for clinical trials or commercial supply for its active pharmaceutical ingredients (APIs): stability studies development in cooperation with partners release of finished dosage forms manufacturing of placebos You get: drug product manufacturing in small batches for clinical trials

8 Quality control Quality control ChemCon ensures the full scale quality control of your project. Quality control is performed on all stages of the process: and test equipment used for QC is fully qualified for cgmp with DQ-IQ-OQ-PQ. raw materials intermediates in-process controls API release Test methods can be either compendial (USP, EP, BP, JP), transferred from our customer or developed by ChemCon. All our analytical Analytical equipment: NMR: 400 MHz, multinuclear; HPLC: DAD, UV, RI, ELS detectors; GPC; LC-MS; GC: liquid injection and headspace units, NPD, ALS, FID detectors; GC-MS; ICP-MS; FT-IR: KBr, ATR, Film; Polarimeter; UV/Vis-Spectrometer; Rheometer; Titration equipment: KF, potentiometric, coulometric; ph determination; MP determination; TOC determination; Polarized Light Microscopy; Ovens for LOD, ROI determination; Bulk density determination; Wet chemistry analytical methods; Stability testing under common ICH conditions; Stress testing; Microbiological release testing: bioburden, identification of pathogens and endotoxin level determination. You get: method development and optimization validation of analytical methods release packages for certification identity, quantitative and limit tests reference standard qualification impurity profiles ICH compliant stability studies

9 Quality assurance Quality assurance ChemCon has an outstanding track record of inspections from German and US authorities. As a chemical development partner to the chemical, pharmaceutical and biotechnology industries, quality is the center of our business activities. We are committed to the highest quality standards and the compliance with EU and FDA regulatory requirements, standard operating procedures and testing methods. All services are performed following or exceeding all current rules and regulations for the protection of health, safety and the environment. Every stage of the development and manufacturing process is controlled by our quality assurance (QA) team to meet customer and regulatory expectations. Through continuous quality management, we ensure the constant improvement of our processes and increase the efficiency of our activities. Our quality management system and independent quality assurance organizations permanently guarantee that our customers receive products and services of the highest quality. Routine internal and external quality audits for cgmp compliance ensure that our quality systems are at the top level of current industry standards. We have never received a critical observation in the company s history. Our customers regularly visit us to inspect ChemCon s quality assurance systems. We have successfully passed approximately 100 customer audits, including audits from some of the top ten pharmaceutical companies worldwide. 3 x by US FDA (2000, 2007, 2011) 5 x by German (European) health authorities (2003, 2006, 2008, 2011, 2013) 15 x by health, safety and environmental agencies approx. 100 x by customers ChemCon is ISO 9001:2008 certified

10 Manufacturing equipment Manufacturing equipment As your partner in drug development, ChemCon provides an advanced environment containing cutting-edge technology and capacity to perform process research, development and manufacturing. We operate state-of-the-art equipment and currently have over 25 fume hoods available for R&D and production support activities. This excellent infrastructure ensures an efficient project realization. Our chromatography services provide an invaluable resource for producing early-stage material without recourse to excessive development time or costs. We are highly experienced and equipped for handling a broad range of organic and inorganic reactions, embracing sophisticated modern technologies, including low temperature reactions, organometallic reactions, chiral synthesis and hydrogenation at elevated temperatures. Our purification capabilities applying chromatography or distillation allow an efficient synthesis of your compounds. various sized reactors up to 250 l pressure reactors up to 100 bar temperature range 60 C to C freeze dryers FDA inspected clean room facilities Class C + D distillation equipment milling equipment centrifuges parallel synthesis equipment chromatographic separation equipment

11 Our four keys to your success Our four keys to your success Experience: more than 1000 projects completed ChemCon has unrivaled chemical experience and expertise. We have already worked for 25 of the largest chemical, pharmaceutical and biotech companies, completed over 1000 projects and produced more than 60 APIs for all phases of drug development, including around 20 commercial APIs, since inception. Quality: more than 100 different inspections and audits successfully passed We have passed more than 100 different inspections and audits in our history. We have never received a critical observation in the company s history. We are ISO 9001 certified and we perform work to GMP, health, safety and environmental standards in compliance with EU and FDA regulatory requirements for cgmp manufacturing. Customer orientation: your chemical challenge will be solved The customer s needs are the center of our activities. ChemCon scientists and technicians deliver precise communication regarding project status as well as documentation for GMP or research purpose. You will receive clear and accurate project updates on a weekly basis from your project chemist. Any intellectual property generated by us under contract is owned by the customer. Clear focus on early R&D stages and small to medium scale manufacturing Small organic or inorganic molecules are our business and we are experts at what we do. Our focus is on production volumes from small to medium scale in early research stages as well as commercial manufacturing, including highly potent APIs. At ChemCon our whole team is committed to serving our customer s needs. Dr. Raphael Vogler, CEO

12 Contact Please contact ChemCon for your custom synthesis demands. We will give your project the highest priority and personal attention: ChemCon GmbH Engesserstr. 4b Freiburg, Germany Phone: +49 (0) Fax: +49 (0) Find us on:

Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers!

Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers! Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers! The Founder s Vision 1992: Dr. Peter Gockel develops synthesis routes of future Active Pharmaceutical Ingredients at the

More information

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Pharma&Biotech Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Custom Manufacturing and Development Services for Highly Potent APIs Pharma&Biotech

More information

NEW CHEMICAL ENTITIES

NEW CHEMICAL ENTITIES NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product

More information

Brand Quality with Asian Advantages

Brand Quality with Asian Advantages Brand Quality with Asian Advantages ScinoPharm Taiwan, Ltd. No.1, Nan-Ke 8th Road, Tainan Science Park, Shan-Hua, Tainan, 74144, Taiwan TEL : 886-6-505-2888 FAX : 886-6-505-2898 Email Contact : [email protected]

More information

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create.

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create. GMP Services Solutions for Clinical Sample Manufacturing 1 EUDRAGIT Products 2 Technical Support 3 Formulation Development Proof of Concept 4 5 GMP Services 6 Advanced Drug Delivery Evonik. Power to create.

More information

Global Lab Capabilities Pharma Biotech

Global Lab Capabilities Pharma Biotech Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical

More information

Dedicated Project Management

Dedicated Project Management Peptides Dedicated Project Management At Lonza, we are committed to our customers success, so it is our mission to help your product reach its full potential. We pride ourselves on delivering high-quality,

More information

Working with ICH Quality Guidelines - the Canadian Perspective

Working with ICH Quality Guidelines - the Canadian Perspective Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction

More information

Overview of Drug Development: the Regulatory Process

Overview of Drug Development: the Regulatory Process Overview of Drug Development: the Regulatory Process Roger D. Nolan, PhD Director, Project Operations Calvert Research Institute November, 2006 Adapted from course taught by Cato Research Background: Roger

More information

Valentina Gualato, Ph.D. Process Development Scientist

Valentina Gualato, Ph.D. Process Development Scientist COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing

More information

Implementing New USP Chapters for Analytical Method Validation

Implementing New USP Chapters for Analytical Method Validation Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: [email protected] Today s Agenda Handling Method Changes vs. Adjustments

More information

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high

More information

Biotechpharma company profile

Biotechpharma company profile Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing

More information

PHARMACEUTICAL REFERENCE STANDARDS

PHARMACEUTICAL REFERENCE STANDARDS PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories

More information

IMPURITIES IN NEW DRUG PRODUCTS

IMPURITIES IN NEW DRUG PRODUCTS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current

More information

Microbiology and Auditing. Don Singer

Microbiology and Auditing. Don Singer Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011 Through the eyes of a Microbiologist Microbiology Audit = Inspection / Investigation Systematic Auditing Planning

More information

Custom Synthesis. Reliable, Flexible and Competitive THE KEY SOLUTION PROVIDER A FINE CHEMICAL COMPANY. About ISOCHEM

Custom Synthesis. Reliable, Flexible and Competitive THE KEY SOLUTION PROVIDER A FINE CHEMICAL COMPANY. About ISOCHEM Custom Synthesis Reliable, Flexible and Competitive About ISOCHEM ISOCHEM manufactures products and offers services that meet the most recent and stringent regulatory standards of the Pharmaceutical industry.

More information

Proficiency Testing In A Global Analytical Environment Benefits & Challenges. AOAC September 2007

Proficiency Testing In A Global Analytical Environment Benefits & Challenges. AOAC September 2007 Proficiency Testing In A Global Analytical Environment Benefits & Challenges AOAC September 2007 1 The Coca-Cola Company The Coca-Cola Company is the largest manufacturer, distributor and marketer of nonalcoholic

More information

GMP Pharma BV. Netherlands

GMP Pharma BV. Netherlands GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Changes to an Approved NDA or ANDA U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) April 2004 CMC Revision

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

colorado EXPERTS TAKING CARE

colorado EXPERTS TAKING CARE CordenPharma colorado EXPERTS TAKING CARE Our History 1946-1965: Arapahoe Chemicals founded with focus on fine organic chemicals 1965-1994: Acquired by Syntex Corporation with focus on Naprosyn and highly

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF GLOBAL AND REGULATORY OPERATIONS AND POLICY

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF GLOBAL AND REGULATORY OPERATIONS AND POLICY SMG 1312.4 FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF GLOBAL AND REGULATORY OPERATIONS AND POLICY OFFICE OF REGULATORY AFFAIRS OFFICE OF OPERATIONS

More information

B i o s o l u t i o n s

B i o s o l u t i o n s B i o s o l u t i o n s Implementation of pharmatracker TM : A case study Prepared by Ocimum Biosolutions Ocimumbio Solutions August 2006 All rights reserved. 2 B i o s o l u t i o n s an ISO 9001:2000

More information

Drug Information Journal, Vol. 33, pp. 755 761, 1999 0092-8615/99

Drug Information Journal, Vol. 33, pp. 755 761, 1999 0092-8615/99 Drug Information Journal, Vol. 33, pp. 755 761, 1999 0092-8615/99 Printed in the USA. All rights reserved. Copyright 1999 Drug Information Association Inc. THE ACTIVE PHARMACEUTICAL INGREDIENTS STARTING

More information

Workshop B Control Strategy

Workshop B Control Strategy ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation

More information

Overview of Pre-Approval Inspections

Overview of Pre-Approval Inspections Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval

More information

Biopharmaceutical Process Evaluated for Viral Clearance

Biopharmaceutical Process Evaluated for Viral Clearance Authored by S. Steve Zhou, Ph.D. Microbac Laboratories, Inc., Microbiotest Division The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate

More information

Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform

Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform CHAPTER 1: Overview CHAPTER 2: Challenges CHAPTER 3: Purification Methodology CHAPTER 4: Results CHAPTER 5: About Eden Biodesign

More information

Non-GMP and GMP Services From Lab Scale R&D to Bulk API Production

Non-GMP and GMP Services From Lab Scale R&D to Bulk API Production Non-GMP and GMP Services From Lab Scale R&D to Bulk API Production (grams to tons) International and All Encompassing Facilities in Asia, Europe, and North America One Stop Manufacturing from Lab to Commercial

More information

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB

More information

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

An Industry White Paper

An Industry White Paper Driving Continuity and Collaboration from Lab Floor to Plant Floor to Top Floor An Industry White Paper Who is AspenTech? AspenTech is a global company founded in 1981 with more than 1,300 employees in

More information

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS. GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS October 2004 APVMA PO Box E240 KINGSTON 2604 AUSTRALIA http://www.apvma.gov.au

More information

Selvita Integrated drug discovery collaborations

Selvita Integrated drug discovery collaborations Selvita Integrated drug discovery collaborations Magdalena Żabka Selvita overview Origins Polish biotechnology research company headquartered in Krakow Mission Resources We deliver comprehensive solutions

More information

Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing

Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing Katherine L. Ulman and Dr. Patricia Rafidison Dow Corning Healthcare About the Authors

More information

FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL

FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL PROGRAM 7356.002F CHAPTER 56 DRUG QUALITY ASSURANCE SUBJECT: ACTIVE PHARMACEUTICAL INGREDIENT (API) PROCESS INSPECTION Revision Note: Program

More information

EuroPeptides 2014: Workshop Considerations for Peptide Contract Manufacturing: Case Study on Scale-up Considerations

EuroPeptides 2014: Workshop Considerations for Peptide Contract Manufacturing: Case Study on Scale-up Considerations EuroPeptides 2014: Workshop Considerations for Peptide Contract Manufacturing: Case Study on Scale-up Considerations Bruce H Morimoto, PhD Executive Director, Applied Translational Medicine Disclaimer

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

LifeTein in Industrial Production of Therapeutic Peptides. Phil Moore, PhD Director of Business Development LifeTein LLC, NJ, USA

LifeTein in Industrial Production of Therapeutic Peptides. Phil Moore, PhD Director of Business Development LifeTein LLC, NJ, USA LifeTein in Industrial Production of Therapeutic Peptides Phil Moore, PhD Director of Business Development LifeTein LLC, NJ, USA 1 Outline Market and Technology Trend LifeTein s Technology portfolio LifeTein

More information

finished goods warehousing available, Northern Labs is capable of handling projects of all sizes.

finished goods warehousing available, Northern Labs is capable of handling projects of all sizes. Northern Labs has the focus, production volume and resources to deliver highly cost-efficient manufacturing for your Northern liquid filling Labs needs. has the focus, production volume and resources to

More information

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs. 15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q2B Validation of Analytical Procedures: Methodology November 1996 ICH Guidance for Industry Q2B Validation of Analytical Procedures: Methodology Additional copies are available from:

More information

Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com)

Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com) M a n u f a c t u r i n g OPERATIONS Technology Transfer of CMC Activities for MAb Manufacturing by Patricia Seymour, Susan Dana Jones, Howard L. Levine With combined 2009 revenues estimated to be over

More information

Custom Synthesis. Reliable, Flexible and Competitive T H E R I G H T C H E M I S T R Y

Custom Synthesis. Reliable, Flexible and Competitive T H E R I G H T C H E M I S T R Y Custom Synthesis Reliable, Flexible and Competitive A b o u t I S O C H E M ISOCHEM is a fine chemical company offering custom manufacturing and catalogue products and its primary market is the manufacture

More information

Introduction to Enteris BioPharma

Introduction to Enteris BioPharma Introduction to Enteris BioPharma Enteris BioPharma Intelligent Solutions for Oral Drug Delivery Privately held, New Jersey based biotech company Owned solely by Victory Park Capital, a large Chicago based

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

Performance and advantages of qnmr measurements

Performance and advantages of qnmr measurements Return to Web Version This is the first of a series of articles related to the launch of new organic CRMs certified by quantitative NMR under double accreditation. In this issue, we focus on CRMs intended

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (11) 204 3R HANDLING AND USE OF REFERENCE STANDARDS IN THE OMCL NETWORK Full document title and reference Document type Legislative

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

Cleaning validation of cleanrooms and preparation equipments

Cleaning validation of cleanrooms and preparation equipments Cleaning validation of cleanrooms and preparation equipments Head of production Central Pharmacy, Geneva University Hospitals EAHP Foundation Seminar: Patient Safety; More About Compounding" 23-25 May,

More information

Expectations for Data to Support Clinical Trial Drugs

Expectations for Data to Support Clinical Trial Drugs Expectations for Data to Support Clinical Trial Drugs Presentation to: APEC Advanced Workshop on Review of Drug Development in Clinical Trials Bangkok Thailand Feb 2-6 2009 Willem Stevens Ph.D., Chief

More information

Good Manufacturing Practices (GMP) for Pharmaceutical Excipients

Good Manufacturing Practices (GMP) for Pharmaceutical Excipients Not for publication. This draft text is for circulation for approval by the Joint Committee and has not been published or otherwise officially promulgated. All rights reserved. This document may be reproduced

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success Pharmaceuticals Production Services Boehringer Ingelheim Our expertise in world-class contract manufacturing for your success Successful partnership Dr Wolfram Carius Head of Corporate Division Pharmaceuticals

More information

Luca Romagnoli, Ph.D. Business Development Manager

Luca Romagnoli, Ph.D. Business Development Manager Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies

More information

How To Test For Leachables

How To Test For Leachables Current FDA Perspective on Leachable Impurities in Parenteral and Ophthalmic Drug products AAPS Workshop on Pharmaceutical Stability Scientific and Regulatory Considerations for Global Drug Development

More information

Revision of The Dissolution Procedure: Development and Validation 1092

Revision of The Dissolution Procedure: Development and Validation 1092 Page 1 of 5 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Revision of The Dissolution Procedure: Development and Validation

More information

Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology-

Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology- Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen -Senior Manager Biotechnology- 2005 by West Pharmaceutical Services, Inc., Lionville, PA All rights reserved.

More information

Delivering a. New Era. of Technical. Support Services

Delivering a. New Era. of Technical. Support Services Delivering a New Era of Technical Support Services 1 Constantly setting new and unique standards for the quality of our products and support of our customers Jeff Layne, Ph.D. Technical Manager, Phenologix

More information

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current

More information

ICH Q7 GMP for Active Pharmaceutical Ingredients

ICH Q7 GMP for Active Pharmaceutical Ingredients National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents ICH Q7 GMP for Active Pharmaceutical Ingredients Part of the Pharmaceutical Biotechnology Training Courses

More information

Non-clinical development of biologics

Non-clinical development of biologics Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Analytical Methods for Cleaning Validation

Analytical Methods for Cleaning Validation Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3 (6): 232-239 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Harmonizing Change Control Processes Globally

Harmonizing Change Control Processes Globally Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses

More information

TYPICAL FDA COMMENTS ON IMPURITY PROFILING IN CTD/CEP/DMF SUBMISSIONS

TYPICAL FDA COMMENTS ON IMPURITY PROFILING IN CTD/CEP/DMF SUBMISSIONS TYPICAL FDA COMMENTS ON IMPURITY PROFILING IN CTD/CEP/DMF SUBMISSIONS By Rajkumar Gupta, Managing Director Perfect Pharmaceutical Consultant Pvt. Ltd and Director Global Institute of Regulatory affairs,

More information

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health Global Education Catalog 2013 2014 and Training Global Expertise Trusted Standards Improved Health USP s mission is to improve global health through public standards and related programs that help ensure

More information

Hamari Chemicals, Ltd.

Hamari Chemicals, Ltd. amari Chemicals, Ltd. Technology for Life 1 Agenda What amari can offer your company amari s Technology The amari Advantage Core Technology unnatural amino acids and peptides; reduction; chiral technologies;

More information

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific

More information

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1) INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY

More information

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective CMC Workshop From Drug Development to Global Supply to Patients April 15-17, 2013, Washington, DC Post-Approval Change Management: Challenges and Opportunities An FDA Perspective Christine M. V. Moore,

More information

Providing Trusted and Innovative Solutions t o the Life Science Communities

Providing Trusted and Innovative Solutions t o the Life Science Communities Providing Trusted and Innovative Solutions t o the Life Science Communities Eurogentec Eurogentec is a leading supplier of trusted and innovative reagents, kits, specialty products and custom research/development

More information

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of

More information

Annex 6. Guidance on variations to a prequalified product dossier. Preface

Annex 6. Guidance on variations to a prequalified product dossier. Preface Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi

More information

Supply Chain Challenges and Risk Management

Supply Chain Challenges and Risk Management Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7

More information

2010 Critical Thinker Series

2010 Critical Thinker Series Malaysian Organisation of Pharmaceutical Industries (MOPI) & PharmEng Technology Presents cgmp Case Studies a T rra ini ing i P rrog rram ffo rr cgmp P rro ffe ss ss ionai l ss 2010 Critical Thinker Series

More information

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH

More information

Engineering for the new pharma reality

Engineering for the new pharma reality NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have

More information

EXTRACTABLES AND LEACHABLES FOR MEDICAL DEVICES: MEETING THE 510 (k) REQUIREMENTS

EXTRACTABLES AND LEACHABLES FOR MEDICAL DEVICES: MEETING THE 510 (k) REQUIREMENTS EXTRACTABLES AND LEACHABLES FOR MEDICAL DEVICES: MEETING THE 510 (k) REQUIREMENTS BIOGRAPHICAL NOTE Kurt Moyer, Ph.D. Director of Research, NSF Pharmalytica Bristol, Connecticut, USA 06010 Tel: 1(860)

More information

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities)

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities) November 2012 EMA/CHMP/ICH/425213/2011 ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities) Step 5 Transmission to CHMP May

More information

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Risk-Based Environmental Monitoring Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Presenter Marsha Stabler Hardiman Over 20 years experience in the

More information

SERVICES FOR. Devices and Combination Products

SERVICES FOR. Devices and Combination Products SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE

More information

Introduction to pharmaceutical technology

Introduction to pharmaceutical technology Introduction to pharmaceutical technology Marie Wahlgren Chapter 1 What is the topics of today Introduction to the course Introduction to the project assignment How to choose a new drug formulation 1 Contacts

More information

Guidance for Industry

Guidance for Industry Guidance for Industry INDs for Phase 2 and Phase 3 Studies Chemistry, Manufacturing, and Controls Information U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

QbD Considerations for Analytical Methods - FDA Perspective

QbD Considerations for Analytical Methods - FDA Perspective QbD Considerations for Analytical Methods - FDA Perspective IFPAC Annual Meeting Baltimore, January 25, 2013 Sharmista Chatterjee, Ph.D. CMC Lead for QbD ONDQA/CDER/FDA Outline Role of analytics in drug

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information